Bausch Health and Lannett have settled a decadelong lawsuit regarding claims the drugmakers colluded to inflate generic drug prices, according to court documents filed in the U.S. District Court for ...

Drug companies Lannett and Bausch agreed to pay $18 million over alleged price-fixing as part of far-reaching lawsuits ...

Washington residents may be eligible for compensation from settlements over generic drug price-fixing. The state secured $17.85 million after two drug companies were found to have inflated prices on ...

The Food and Drug Administration on Tuesday published a list of more than 200 brand name drugs without generic alternatives on the market. While the list leaves many drugmakers susceptible to more ...

Health care workers are changing how they counsel patients. Experts are using our database to support their research. And ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

Generic drug suppliers weigh predictable and unpredictable factors that could impact the category in 2025. “This is the latest example of our actions to expand our portfolio in growing therapeutic ...